AVITA Medical appoints Cary Vance as permanent CEO, Jan Stern Reed as Board Chair

AVITA Medical, Inc.

Cary Vance named President and CEO effective April 30, 2026; served as Interim CEO since October 2025.
Jan Stern Reed appointed Chair of the Board; had been Lead Independent Director since October 2025.
Vance receives $702k base salary, 80% bonus target, and $3.354M in equity awards subject to stockholder approval.
Employment agreement: 3-year initial term; severance of 18 months base salary plus COBRA if terminated without cause.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Jan Stern Reed

Chair of the Board

RCEL · AVITA Medical, Inc.

Effective: 2026-04-29
Filed: May 1, 2026, 7:59 PM ET

the Board appointed Jan Stern Reed as Chair of the Board while simultaneously terminating the Lead Independent Director position that she had been serving since October 2025

Appointed

Cary Vance

President and Chief Executive Officer

RCEL · AVITA Medical, Inc.

Effective: 2026-04-30
Filed: May 1, 2026, 7:59 PM ET

the Board of Directors (the “Board”) of AVITA Medical, Inc (the "Company") appointed Cary Vance as President and Chief Executive Officer ("CEO"), effective April 30, 2026

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Jan Stern Reed was appointed as Chair of the Board at AVITA Medical, Inc..

Action: appointed
Role: Chair of the Board

Exact text from the filing

the Board appointed Jan Stern Reed as Chair of the Board while simultaneously terminating the Lead Independent Director position that she had been serving since October 2025

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Cary Vance was appointed as President and Chief Executive Officer at AVITA Medical, Inc..

Action: appointed
Role: President and Chief Executive Officer

Exact text from the filing

the Board of Directors (the “Board”) of AVITA Medical, Inc (the "Company") appointed Cary Vance as President and Chief Executive Officer ("CEO"), effective April 30, 2026

View on SEC.gov

AVITA Medical, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-26-201662

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.